Syra Health Corp. (NASDAQ:SYRA) Short Interest Down 44.5% in March

Syra Health Corp. (NASDAQ:SYRAGet Free Report) saw a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 403,800 shares, a decrease of 44.5% from the March 15th total of 728,200 shares. Approximately 4.1% of the shares of the company are short sold. Based on an average daily trading volume, of 2,220,000 shares, the days-to-cover ratio is currently 0.2 days.

Syra Health Stock Performance

SYRA stock traded down $0.02 during mid-day trading on Friday, hitting $0.10. The company had a trading volume of 3,847,930 shares, compared to its average volume of 839,555. The firm has a market cap of $1.18 million, a PE ratio of -0.16 and a beta of 3.47. Syra Health has a 12 month low of $0.10 and a 12 month high of $2.27. The stock’s fifty day moving average price is $0.32 and its two-hundred day moving average price is $0.39.

Syra Health (NASDAQ:SYRAGet Free Report) last released its quarterly earnings results on Tuesday, March 11th. The company reported ($0.05) earnings per share for the quarter. The business had revenue of $2.00 million during the quarter, compared to analysts’ expectations of $2.01 million. Syra Health had a negative net margin of 54.90% and a negative return on equity of 131.94%. Equities analysts anticipate that Syra Health will post -0.53 earnings per share for the current year.

About Syra Health

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.

Featured Articles

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.